Note to Users: The videos in these courses were created in Adobe Flash which is no longer supported on the internet. To access this content, click on capital letter D below where a video occurs to see text version of video content. In some instances, there is no capital letter D because only music was playing.

FDA Overview of Biosimilar Products 

Credit is no longer available for this course.

This first course about biosimilar products provides an understanding of biological products and biosimilar products and a description of FDA’s general approach to the development and approval of biosimilar products. The target audience for this course is healthcare professionals, including physicians, physician assistants, nurses, nurse practitioners, pharmacists., and pharmacy technicians.

FDA’s Role in Public Health: Drug Efficacy, Safety, Quality, and Beyond

Credit is no longer available for this course.

The purpose of this course is to educate a national audience of health care providers, industry, and consumers about the basics of the FDA drug regulatory process and the science that supports CDER’s mission. The course will also educate the nation’s health care providers about their role in communicating drug information to their patients. This updated CDERLearn course replaces the former CDERLearn course, "The Past, Present, and Future of Human Drug Regulation."

A new continuing education (CE) version of this course will be developed in 2020.